Morphine sulfate 15mg, 30mg, 60mg, 100mg, 200mg; ext-rel tabs. Serious and life-threatening risks from use of MS Contin: Addiction, abuse, and misuse; Life-threatening respiratory depression; ...
A patient has been receiving MS Contin® (controlled-release oral morphine), 60 mg twice daily, for about 22 months. She had excellent pain relief for the first 13 months, but since then has had ...
Lupin Ltd has informed BSE regarding a Press Release dated January 13, 2017, titled "Lupin Launches Generic MS Contin ER Tablets in the US".Source : BSE Advisory Alert: It has come to our attention ...
WAYNE, Pa., June 25, 2015-- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain ...
Citing IMS MAT September 2016 data, the company said MS Contin ER tablets had sales of USD 282.9 million in the US market. Citing IMS MAT September 2016 data, the company said MS Contin ER tablets had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results